Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings, method therefor
US7196115B2 · kind B2 · utility
33Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2002 |
| Grant date | Mar 27, 2007 |
| Priority date | — |
| Expiry date | Dec 30, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the bioactivity of taxanes isolated from the leaves of Himalayan Yew tree Taxus wallichiana against human cancer cell lines grown in-vitro and subsequent identification of brevifoliol [1] as anticancer agent useful in the treatment of various types of cancer in humans
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.